Fortress Biotech (FBIO) vs Tenax Therapeutics (TENX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Fortress Biotech (FBIO) has outperformed Tenax Therapeutics (TENX) over the past year, losing 33.1% versus a loss of 74.5%. Over five years, FBIO leads with a -95.6% price change compared with -99.9% for TENX. Tenax Therapeutics is the larger company by market cap ($69.4 million vs $68.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FBIO | TENX |
|---|---|---|
| Share price | $2.07 | $1.86 |
| Market cap | $68.87M | $69.42M |
| 1-day change | +1.23% | -2.88% |
| YTD return | -44.26% | -84.33% |
| 1-year return | -33.11% | -74.50% |
| 5-year return | -95.58% | -99.93% |
| P/E ratio (TTM) | 0.75 | — |
| EPS (TTM) | $2.76 | $-1.48 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.53 | $19.40 |
| 52-week low | $2.00 | $1.31 |
| Distance from 52-week high | -54.42% | -90.44% |
| Average volume | 507.86K | 5.44M |
| Shares outstanding | 33.35M | 37.42M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- FBIO has outperformed TENX by 41.4 percentage points over the past year.
FBIO vs TENX FAQ
Which is bigger, Fortress Biotech or Tenax Therapeutics?
Tenax Therapeutics (TENX) is larger, with a market capitalization of $69.42M compared with $68.87M for Fortress Biotech (FBIO).
Which stock has performed better over the past year, FBIO or TENX?
FBIO returned -33.11% over the past 12 months, compared with -74.50% for TENX (price return, excluding dividends). Past performance does not predict future results.
Are Fortress Biotech and Tenax Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.